Great genetic variation in pancreatic cancer, study shows

Great genetic variation in pancreatic cancer, study shows
Image: Pancreatic cancer cell. Credit: Anne Weston, LRI, CRUK, Wellcome Images.

A new study published recently in Nature details the complexity of genetic variation found in pancreatic cancer cells. The ability to identify and understand the early mutations involved with the disease may lead to the discovery of new drug targets.

Around 97 to 98 per cent of people with pancreatic cancer die within five years of diagnosis. The disease is so deadly because it often exhibits no symptoms, and hence is only diagnosed when at an advanced stage.

The behind pancreatic cancer are complex and varied, with tumour cells exhibiting a variety of . New research from scientists, including those from the
Wellcome Trust Sanger Institute, sequenced the DNA from the primary and secondary tumours, known as , of 13 patients in order to compare the mutations.

The sequencing revealed that 17 per cent of the genomic mutations were shown to cause a distinctive pattern of DNA rearrangement, which the researchers have termed a 'fold-back inversion'.

"Of all the types of cancer we've studied, this particular DNA rearrangement seems to be distinctive for pancreatic cancer," explains Dr. Peter Campbell, from the Wellcome Trust Sanger Institute, who led the research.

This fold-back inversion is caused when a DNA region is duplicated following a breakage. These breaks can occur repeatedly during cell division, leading to an explosion of genomic instability.

This instability is found early on in the development of pancreatic cancer and can lead to the incorrect expression and deletion of genes. Given the random nature of mutations, there can be huge between cells in the same pancreatic tumour.

Once a pancreatic tumour cell has gained the necessary mutations, it is able to move around the body, forming metastases. What this research showed is that the continue to mutate even after they have left the pancreas, potentially enabling the to survive in other organs, such as the lungs or liver.

"Why would a pancreatic cell be able to survive in the lung? There's no reason for that to happen," asks Dr. Campbell. "Our results suggest the cancer cells do not stop evolving once they start invading tissue - metastases seem to be able to 'fine tune' their genome to be able to survive in different hostile environments,” he adds.

Explore further

Forces for cancer spread: Genomic instability and evolutionary selection

More information: Campbell PJ, et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 28 October 2010.
Provided by Wellcome Trust
Citation: Great genetic variation in pancreatic cancer, study shows (2010, November 9) retrieved 7 May 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments